Mucosilent Gegen Reizhusten (Levodropropizine)

Levodropropizine acts peripherally by blocking sensory C‑fibers in the respiratory mucosa. This inhibition reduces the afferent signals that trigger the cough reflex, decreasing cough intensity without depressing central nervous system activity.

The appropriate dose of levodropropizine is determined by the prescribing healthcare professional based on the patient’s age, weight, and clinical condition. Patients should follow the dose instructions provided by their prescriber and the product label.

Safety data for levodropropizine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using this medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Levodropropizine is a peripheral, non‑opioid antitussive, unlike central‑acting agents such as codeine. It offers cough relief without the sedation or dependence potential associated with opioid‑based cough medicines, making it suitable for patients where central nervous system effects are undesirable.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture, direct sunlight and extreme temperatures to maintain its stability and efficacy.

Mucosilent Gegen Reizhusten is taken orally as directed by a healthcare professional. The tablet or liquid should be swallowed with water, and the dose timing should follow the prescriber’s instructions, typically with or without food.

Serious but rare risks include allergic reactions such as rash, itching, swelling, or anaphylaxis, as well as hepatic dysfunction indicated by elevated liver enzymes. Patients should seek immediate medical attention if they experience any signs of a severe allergic response.

Individuals with known hypersensitivity to levodropropizine or any excipients in the formulation should avoid using the product. Patients with severe liver impairment or those taking contraindicated medications, such as MAO inhibitors, should consult a physician before use.